Table 4.
Creatinine, estimated glomerular filtration rate (eGFR), and trefoil factor 3 (TFF3) concentrations in serum of men (n = 10) and women (n = 9) one to two days, six months, and one year after kidney transplantation assessed using ELISA and Luminex ((Med., median; Q1, lower quartile; Q2, upper quartile).
| Level in | TFF3 (ng/mL) Med (Q1–Q2) |
||||||
|---|---|---|---|---|---|---|---|
| Men | Women | ||||||
| Time after Transplantation | |||||||
| One to Two Days | Six Months | One Year | One to Two Days | Six Months | One to Two Years | ||
| ELISA | serum | 69.22 (30.48–87.76) |
14.80 (13.29–24.89) |
12.69 (8.18–17.81) |
63.65 (52.04–76.98) |
18.34 (12.76–22.89) |
18.72 (15.32–20.92) |
| urine | 137.0 (66.62–266.0) |
138.5 (34.91–333.5) |
89.27 (49.52–290.8) |
213.8 (172.6–273.9) |
53.47 (45.21–212.5) |
184.4 (68.60–212.9) |
|
| Luminex | serum | 14.04 (9.63–22.28) |
3.24 (2.71–5.98) |
3.90 (2.23–6.02) |
9.56 (8.24–13.95) |
4.61 (2.89–8.11) |
5.54 (3.26–6.97) |
| urine | 28.78 (14.01–41.06) |
50.69 (12.77–64.59) |
36.43 (13.87–83.27) |
57.25 (25.14–72.29) |
22.20 (18.24–76.40) |
52.67 (24.02–78.24) |
|
| Level in |
Creatinine (mg/dL) in serum
Med (Q1–Q2) |
||||||
| Men | Women | ||||||
| Time after transplantation | |||||||
| One to two days | Six months | One year | One to two days | Six months | One year | ||
| serum | 5.36 (3.31–9.04) |
1.47 (1.18–1.63) |
1.40 (1.22–1.54) |
3.81 (2.58–4.05) |
1.35 (1.03–1.48) |
1.21 (1.17–1.58) |
|
|
GFR (in mL/min/1.73)
Med (Q1–Q2) |
|||||||
| Men | Women | ||||||
| Time after transplantation | |||||||
| One to two days | Six months | One year | One to two days | Six months | One year | ||
| estimated | 11 (7–19) | 58 (47–69) | 59 (52–66) | 14 (12–21) | 47 (41–57) | 49 (39–54) | |